We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. ACADIA Pharmaceuticals Inc. is one of the ...

Company to host conference call and webcast on Wednesday, February 25, 2026, at 4:30 p.m. Eastern Time Investor Contact: Acadia Pharmaceuticals Inc. Al Kildani (858) 261-2872 ir@acadia-pharm.com ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2026 financial results on Wednesday, May 6, 2026, after the close of the U.S. financial markets. Acadia’s ...

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101 ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251105491823/en/ Investor Contact: Acadia Pharmaceuticals Inc. Al Kildani (858) 261 ...

-- Recently published expert consensus recognizes trofinetide as part of the standard of care for Rett syndrome and highlights the importance of flexible, patient-centered treatment approaches ...

- 2028 projected combined net sales of approximately $1.7 billion including ~$1 billion for NUPLAZID ® and ~$700 million for DAYBUE ® - Top-line results from the Phase 2 RADIANT study of remlifanserin ...

Connecticut-based fund Braidwell bought 2,378,655 shares of Acadia Pharmaceuticals in the third quarter, representing a new position valued at about $50.8 million as of September 30. The transaction ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is one of the best innovative healthcare ...

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on ACADIA Pharmaceuticals (NASDAQ:ACAD) in the last three months. The table below provides a ...

Company to host conference call and webcast on Wednesday, February 25, 2026, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after ...